Investigation of the therapeutic effect of Dapagliflozin in infertile women with polycystic ovary syndrome (PCOS) undergoing IVF

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240303061157N1

Enrollment

Registered

2024-03-16

Start date

2024-04-03

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Control group: Received oral rehydration salts (ORS) twice a day for 8 weeks. Intervention 2: Intervention group: Received Metformin drug with a dose of 1000 mg per day for 8 weeks. I

Eligibility

Sex/Gender

Female

Age

20 Years to 42 Years

Inclusion criteria

Inclusion criteria: Infertile women with classic polycystic ovary syndrome Infertile women between 20 and 42 years old

Exclusion criteria

Exclusion criteria: Hypersensitivity to metformin or SGLT-2 inhibitors Pregnancy Diabetes Male infertility

Design outcomes

Primary

Measure	Time frame
No. of Oocyte retrieved. Timepoint: once, in day of puncture. Method of measurement: Oocyte retrieval was performed by ultrasound-guided transvaginal aspiration using a single-lumen needle.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactForogh Forghani

Zahedan University of Medical Sciences

f.forghani@zaums.ac.ir+98 54 3337 2013

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026